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Protein phosphorylation regulates many aspects of cellular function, including cell prolifera-
tion, migration, and signal transduction. An efficient strategy to isolate phosphopeptides from
a pool of unphosphorylated peptides is essential to global characterization using mass
spectrometry. We describe an approach employing isotope tagging reagents for relative and
absolute quantification (iTRAQ) labeling to compare quantitatively commercial and prototypal
immobilized metal affinity chelate (IMAC) and metal oxide resins. Results indicate a prototype
iron chelate resin coupled to magnetic beads outperforms either the Ga3-coupled analog,
Fe3, or Ga3-loaded, iminodiacetic acid (IDA)-coated magnetic particles, Ga3-loaded Cap-
tivate beads, Fe3-loaded Poros 20MC, or zirconium-coated ProteoExtract magnetic beads. For
example, compared with Poros 20MC, the magnetic metal chelate (MMC) studied here
improved phosphopeptide recovery by 20% and exhibited 60% less contamination from
unphosphorylated peptides. With respect to efficiency and contamination, MMC performed as
well as prototypal magnetic metal oxide-coated (TiO2) beads (MMO) or TiO2 chromatographic
spheres, even if the latter were used with 2,5-dihydroxybenzoic acid (DHB) procedures. Thus
far, the sensitivity of the new prototypes reaches 50 fmol, which is comparable to TiO2 spheres.
In an exploration of natural proteomes, tryptic (phospho)peptides captured from stable
isotopic labeling with amino acids in cell culture (SILAC)-labeled immunocomplexes follow-
ing EGF-treatment of 5 107 HeLa cells were sufficient to quantify stimulated response of over
60 proteins and identify 20 specific phosphorylation sites. (J Am Soc Mass Spectrom 2007, 18,
1932–1944) © 2007 American Society for Mass SpectrometryCharacterization of protein phosphorylation sta-tus, especially following stimulated transduc-tion events, can provide mechanistic insights
into the biological basis of signaling, cell cycle progres-
sion, adhesion, migration, and numerous other func-
tions. Nowadays, the identification of phosphorylation
sites in a complex milieu is carried out mainly by mass
spectrometry. However, the sensitivity of analysis is
largely hindered by low stoichiometry of phosphoryla-
tion, the reversible nature of the modification, and
relatively weak ionization of phosphopeptides. It has
been noted that enrichment of phosphopeptides from a
pool of unphosphorylated peptides dramatically im-
proves the success frequency for characterization.
Several methods for enriching phosphorylated pep-
tides have been reported, including chemical derivati-
zation of phospho-residues [1–5], antibody-based cap-
ture, immobilized metal affinity chromatography
(IMAC) [6–10], enrichment on metal oxide surfaces
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doi:10.1016/j.jasms.2007.08.001[11–13], strong cation exchange chromatography [14,
15], and phosphoramidate chemistry [16, 17]. For exam-
ple, anti-phosphotyrosine antibodies have been used
successfully to enrich tyrosine phosphorylated proteins
and peptides [18–22]. Some authors report hundreds of
phosphopeptides are identified in yeast using IMAC
strategies [7]. More recently, TiO2 chromatographic
spheres were utilized to isolate phosphopeptides with
high specificity in the presence of 2,5-dihydroxybenzoic
acid (DHB) in the loading buffer [11, 12].
Although 32P-radiolabeled phosphopeptides have
been used to quantify capture efficiency of a few IMAC
materials in MS studies, most evaluations of capture
materials have been performed in a qualitative fashion
[9, 23]. New techniques make it possible to evaluate
phosphoprotein and phosphopeptide capture efficien-
cies without using radioactive labels. Among them,
iTRAQ is a straightforward multiplexed strategy for
protein and peptide quantification [24–27]. Briefly,
iTRAQ reagents are isobaric peptide reactive labels
prepared with stable isotopes substituted at select
atomic positions. They allow quantitative comparison
of up to four samples each labeled with an equivalent
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are mixed, and during collision induced dissociation,
the iTRAQ tags fragment to yield predictable but dis-
tinct reporter ions.
SILAC is a method used to label proteins in vivo
with stable isotopes of atomic nuclei. Two cultures of
cells are grown, one using heavy isotopically labeled
amino acids and the other using their light congeners.
The cultures may be treated differently, for example one
may be exposed to a drug or other potential modifier,
and the resulting protein abundances deduced directly
by comparison of the MS signal intensity of peptides
from known proteins [28].
In the present study, we first used iTRAQ labeling of
a standard mixture to quantitatively evaluate a variety
of metal chelate (MC) and metal oxide (MO) affinity
materials with respect to their selectivity in phos-
phopeptide isolations. We then characterized the per-
formance of the most selective resins using peptides
from immunoprecipitated phosphoproteins derived
from EGF-stimulated cell culture. Our results indicate
that, when adapted to magnetic Dynabeads, the Fe3
chelator of this study (MMC) performs as well as TiO2
coated Dynabeads (prototype, MMO) or chromato-
graphic Titansphere (TiO2 spheres) and better than
several other alternative materials for phosphopeptide
enrichment. This conclusion was borne out with both
standard mixtures and with phosphopeptides isolated
from cultured cells. Using a SILAC strategy on 5  107
HeLa cells deprived of serum overnight, we identified
over 60 proteins that respond specifically to 5 min EGF
stimulation and elucidated 25 uniquely affected phos-
phorylation sites, several of which are novel.
Materials and Methods
Materials
Magnetic beads coated with zirconium oxide were pur-
chased from Calbiochem (ProteoExtract phosphopeptide
capture kit, cat. no. 525250, San Diego, CA). Titansphere, 5
um TiO2 chromatography-grade spheres (TiO2 spheres)
were purchased from GL Sciences Inc. (Torrance, CA). A
phosphopeptide standard mixture [angiotensin II
(DRVYIHPF, 1046.54), angiotensin I (DRVYIHPFHL,
1296.88), myelin basic protein fragment 104-118
(GKGRGLSLSRFSWGA, 1578.85), pTpY peptide (MAP
kinase fragment 177–189, DHTGFLpTEpYVATR,
1669.67), pY peptide (insulin receptor fragment 1142-
1153 (TRDIpYETDYYRK, 1702.75), pT peptide
(VPIPGRFDRRVpTVE, 1720.89), pS peptide (RII phos-
phopeptide fragment 81–99, DLDVPIPGRFDRRVpS-
VAAE, 2192.08)] was purchased from Invitrogen (cat.
no. P33357).
HeLa cells were purchased from ATCC. iTRAQ,
NuPAGE gel, NuPAGE sample buffer, SimplyBlue
SafeStain, NuPAGE transfer buffer, WesternBreeze,
Captivate beads, TiO2 coated Dynabeads-(prototype,
MMO), Dynabeads-MyOne-tosylactivated beads (cat.no. 655-01), DMEM medium, SILAC/DMEM (cat. no.
SP10001 that contains dialyzed FBS, [U-13C6] L-lysine
and lysis buffers), [U-13C6,
15N4] L-arginine (cat. no.
MS10009), recombinant human EGF, and monoclonal
anti-phosphotyrosine antibodies (PY-Plus, a monoclo-
nal cocktail containing clones PY-7E1 and PY20; cat. no.
13-6600) were from Invitrogen.
The Nexus tetradentate metal chelator (Valen Bio-
tech, Inc., Atlanta, GA) was coupled to Dynabeads-
MyOne tosylactivated beads (MMC) according to G.
Pevow, U.S. patent application 20020019496. Immobili-
zation of anti-phosphotyrosine antibody (PY-Plus) on
Dynabeads-MyOne tosylactivated beads was per-
formed according to the manufacturer’s instruction.
Monoclonal 4G10 anti-phosphotyrosine antibody and
agarose-conjugated 4G10 anti-phosphotyrosine anti-
body were purchased from Upstate Biotechnology Inc.
(cat. no. 16-199, Lake Placid, NY). -Cyano-4-hydroxy
cinnamic acid (CHCA), 2,5-dihydroxybenzoic acid
(DHB), GaCl3 and FeCl3 were purchased from Sigma
(St. Louis, MO). Trypsin was obtained from Promega
(Fitchburg, WI). Poros 20 MC and Poros R2 resin were
purchased from Applied Biosystems (Foster City, CA).
Geloader tips (10 L size) were purchased from Eppen-
dorf (Westbury, NY).
iTRAQ Labeling and Isolation of Phosphopeptides
for MS Analysis
Phosphopeptide standard mixtures were isotopically
labeled with iTRAQ 114, 115, 116, or 117 according to
manufacturer’s instructions. Magnetic beads or resins
derivatized with different functional ligands were pre-
loaded with Fe3 or Ga3 by the respective manufac-
turers. Isolation of phosphopeptides using traditional
metal chelate resins followed the basic procedure de-
scribed in the Captivate phosphopeptide isolation kit
(Invitrogen). Briefly, the capture medium was equili-
brated with binding/washing buffer A (50 mM sodium
acetate in 20% ethanol, pH 4.0). Upon phosphopeptide
binding, the capture medium was washed five times
with buffer A, followed by elution with 10 L of buffer
B (50 mM sodium phenylphosphate in 0.3 N ammo-
nium hydroxide). To isolate phosphopeptides using
MMO or TiO2 spheres, 0.1% trifluoroacetic acid (TFA)
or 300 mg/mL DHB/80% acetonitrile/0.1% TFA was
used as binding buffer and 80% acetonitrile in 0.1% TFA
was used as washing buffer [12].
Aliquots of iTRAQ labeled peptides (typically 5 L
of 2 pmol/L stock) were acidified with 2 L of 50%
acetic acid, diluted with 36 L binding buffer, and then
incubated with 8 L of 50 mg/mL magnetic beads for
10 min with repetitive pipetting, or they were passed
through an Eppendorf GeLoader tip prepacked with
Poros 20MC or TiO2 spheres (3 mm packing length).
After extensive washing, phosphopeptides were eluted
with 10 L of elution buffer as described above.To quantitatively compare capture efficiency, phos-
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tries were mixed and acidified with 4 L of 50% acetic
acid, followed by desalting with a self-packed Poros R2
tip column. Phosphopeptides were eluted directly onto
a MALDI plate and mixed with CHCA matrix at 1:1
ratio, followed by analysis using a 4700 proteomics
analyzer (Applied Biosystems).
Before sample analysis, the CID gas cell was purged
to obtain stable isotopic ratios within the reporter ion. A
total of 14,000 laser shots were used to average the
signals of fragmenting ion set. Rather than invoking
automated iTRAQ quantification in the GPS Explorer
software, we manually evaluated the relative abun-
dance of reporter ions in the tandem mass spectrometry
(MS/MS) spectra by integration in Data Explorer soft-
ware (PerSeptive Biosystems, Inc., Framingham, MA)
wherein the most intense reporter ion was set at 100% in
intensity.
SILAC Labeling and Isolation of Phosphopeptides
for LC-MS Analysis
HeLa cells were maintained in DMEMmedium contain-
ing 10% FBS. For SILAC labeling, aliquots of HeLa cells
were propagated for at least six doublings (10 days) in
SILAC DMEM media containing 10% dialyzed FBS and
supplemented with light L-lysine and light L-arginine
(light medium) or heavy [U-13C6] L-lysine and heavy
[U-13C6,
15N4] L-arginine (heavy medium). After over-
night starvation with the corresponding serum-free
light or heavy medium, HeLa cells labeled in heavy
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Wash
Aliquot of 10 pmol
Wash
Eluate
Resin A
crossover
C18 zip tip
4700 Proteomics MALDI-TOF-TOF(MS/MS)
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Figure 1. Experimental strategy for quantitative comparison of a
variety of metal resins using iTRAQ. Peptide standard mixtures
were isotopically labeled with iTRAQ reagents. Aliquots of la-
beled peptides were then incubated with a variety of IMAC or
metal oxide resins to isolate phosphorylated peptides. Peptides
eluted from the beads were mixed accordingly. Reverse capture of
phosphopeptides could be performed to reduce bias. Phos-
phopeptide mixture was desalted using a C18 tip column, followed
by the analysis of MALDI-TOF-TOF. Quantification was con-
ducted manually in the MS/MS spectra.medium (50  106 cells) were stimulated with 150ng/mL EGF for 5 min while HeLa cells labeled with
light medium (50 106 cells) remained untreated. Upon
stimulation, heavy-labeled cells and light-labeled cells
were lysed immediately in NP-40 lysis buffer contain-
ing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% NP-40,
0.1% sodium deoxycholate, 1 mMNa3VO4, 10 mMNaF,
and protease inhibitor cocktail. In some cases, crossover
stimulation was also performed to verify the identity of
phosphopeptide as well as the isotopic ratio.
Cell lysates were clarified by centrifugation at
100,000  g for 15 min and the mixed cell lysates were
immunoprecipitated with 50 g of either phosphoty-
rosine antibody (PY-Plus) conjugated to Dynabeads or
4G10 phosphotyrosine antibody conjugated to agarose
beads. After mixing by gentle rotation for 2 h at 4 °C,
the Dynabeads were captured with a magnet, whereas
the agarose beads were harvested by centrifugation.
The beads were washed five times with lysis buffer and
then eluted with 50 L of 100 mM glycine (pH 2.5). The
eluates were neutralized with 1 M Tris, reduced with 10
mM DTT and alkylated with 30 mM iodoacetamide in 1
 SDS sample buffer, and then separated on SDS-
PAGE. Alternatively, the immunocomplexes were di-
rectly eluted with 50 L of SDS sample buffer contain-
ing 50 mMDTT, followed by the analysis of SDS-PAGE.
Protein bands were excised from gels and subjected to
in-gel tryptic digestion as described [29]. Peptide ex-
tracts were dried using a Speed Vac.
Approximately one-third of the peptide extract
was used for protein identification using nanoelectro-
spray LC-MS (Q-TOF premier; Waters Corporation,
Milford, MA) or MALDI-TOF-TOF (4700 Proteomics
Analyzer; Applied Biosystems) [29]. The rest of the
sample was incubated with 250 g of MMC-Fe3 or
MMO (TiO2) for 10 min in 24 L of binding buffer to
isolate phosphopeptides. In either case the resins
were washed five times with washing buffer and then
eluted with 10 L of elution buffer. The eluted
phosphopeptides were acidified with 2 L of 50%
acetic acid and then desalted with a self-packed Poros
R2 tip column, followed by analysis using nanoelec-
trospray LC-MS or MALDI-TOF-TOF. The Mascot
protein score obtained from isolated phosphopep-
tides was generally low as it is based on one or two
peptide hits. To improve the relevance of phospho-
Table 1. Relative efficiency of phosphopeptide capture
Capture media
Relative
efficiency
MMC-Fe3 1
MMC-Ga3 0.1  0.05
Prototype IDA coated Dynabeads-(Fe3) 0.2  0.08
Prototype NTA coated Dynabeads-(Fe3) 0.85  0.05
Poros 20MC-IDA-Fe3 0.82  0.05
Captivate-Ga3 0.1  0.05
Calbiochem ZrO2 0.1  0.05
Titansphere® TiO2 (GL Sciences) 0.95  0.05
Prototype TiO2-coated Dynabeads (MMO) 0.95  0.05
pYET
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of enriched phosphopeptides with LC-MS analysis of
all peptides extracted from in gel digests. Because the
proteins loaded on the gel were immunoprecipitated
with anti pTyr, these sum of these two targeted
approaches conducted under SILAC labeling gives
high confidence in distinguishing response to EGRF
stimulus.
For LC-MS analysis, an Atlantis dC18, 3 m, 100 m
 100 mm column (Waters Corporation) was used for
peptide separation. An elution gradient of 5% to 45%
(vol/vol) acetonitrile in 0.1% formic acid over 45 min,
and then 45% to 95% acetonitrile in 0.1% formic acid
over 5 min was used. In the data-dependent mode, four
component trigger functions were used to acquire
MS/MS data with 1.9 s scan time. For MALDI-TOF-
TOF analysis, the desalted phosphopeptides were di-
rectly spotted on MALDI plates, and mixed with CHCA
matrix at 1:1 ratio. A total of 14,000 shots were used to
average each MS/MS spectrum.
Raw data files from Q-TOF instrument were pro-
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and then searched against NCBInr database (April 15,
2006) using the Mascot search algorithm version 2.2.
The searches were constrained to tryptic peptides with
one missed cleavage allowed. Oxidation of methionine
residues, cysteine carbamidomethylation, phosphoryla-
tion, heavy Lys and heavy Arg with  mass of 6 and 10
Da, respectively, were selected as variable modifica-
tions. The mass tolerance of the precursor peptide ion
was set at 50 ppm and mass tolerance for the MS/MS
fragment ions was set at 0.2 Da. The Mascot output
showed peptides labeled with either light or heavy Lys
and/or Arg. Quantification of peptide pair was per-
formed and validated manually by examining both MS
and MS/MS spectrums.
Raw data files obtained from the 4700 Proteomics
Analyzer were processed using GPS Explorer (version
3.0, Applied Biosystems) and then searched against
NCBI database. Oxidation of methionine residues, cys-
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1936 LIANG ET AL. J Am Soc Mass Spectrom 2007, 18, 1932–1944One missing cleavage was allowed. Mass tolerances for
precursor and MS/MS fragment were set at 150 ppm
and 0.5 Da, respectively. The MS/MS spectra of phos-
phopeptides were examined manually to confirm the
neutral loss of phosphoric acid.
Results and Discussion
Experimental Strategy
In Figure 1, we describe an iTRAQ-based strategy to
quantitatively compare the phosphopeptide capture
efficiency of different selective capture media, two at
a time. Peptide standard mixtures containing serine,
threonine, or tyrosine-phosphorylated peptides and
unphosphorylated peptides were chemically labeled
with iTRAQ-114, 115, 116, or 117, respectively. Ali-
quots of the labeled peptides were then incubated
with the same amount of capture media. For compar-
ison of Medium A to Medium B, phosphopeptides
eluted from Medium A were mixed with phos-
phopeptides eluted from Medium B. To eliminate
bias stemming from unequal sample preparation, we
performed crossover experiments; that is, phos-
phopeptides with a given iTRAQ label were isolated
on reciprocal media and mixed again. The eluted
phosphopeptide mixture was desalted using a tip
column prepacked with Poros R2 resin and then
analyzed using a MALDI-TOF-TOF instrument.
Quantification was based on the relative intensity
ratio of reporter ions in the MS/MS spectrum.
No single chromatographic material has proven ad-
equate to bind all phosphopeptides [30]. For example, it
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Figure 3. An example of quantitative comparison of unphos-
phorylated peptides carried over during phosphopeptide enrich-
ment. Phosphopeptides were isolated using either Poros 20MC or
MMC (see the Experimental section) as described above. Unphos-
phorylated peptides carried over were analyzed by MALDI-TOF-
TOF.has been shown that Poros R2 resin retains only certainsubsets of phosphopeptides, depending primarily on
sequence and hydrophobicity [31]. In these cases, the
sequential use of multiple reverse phase materials, such
as Poros R1, R2, R3, and graphite powder, improves the
retention of phosphopeptides [31, 32]. However, failure
to incorporate all of these resins does not affect the
interpretation of our results because the protocol is
designed to measure the relative effectiveness of resins
used upstream in the capture of phosphopeptides. At
the point the recovered peptides are desalted on Porous
R2, they exist as a mixture of heavy- and light-labeled,
sequence-matched phosphopeptides. Hence, losses on
the Porous R2 resin will not introduce bias into the
relative measurement.
Quantitative Comparison of Phosphopeptide
Capture Media Using Standard Peptide Mixtures
Metal chelate resins preloaded with either Fe3 or
Ga3 metal ions and other media were used to isolate
iTRAQ labeled phosphopeptides, as described above.
Phosphopeptides isolated from Medium A and Me-
dium B were mixed, desalted, and analyzed by
MALDI-TOF-TOF. The relative efficiency of phos-
phopeptide capture was determined as the intensity
ratio of the reporter ions. The capture efficiency of
MMC-Fe3 was assigned an arbitrary-ranking value
of 1. The values for all other capture media were
calculated relative to the capture efficiency of MMC-
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Figure 4. Sensitivity of phosphopeptide enrichment using MMC.
One L of 50 mg/mL bead suspension was incubated with either
50 fmol or 100 fmol of peptide mixtures. After extensively wash-
ing, phosphopeptides were eluted directly onto a MALDI plate
and mixed with -cyano-4-hydroxy cinnamic acid matrix, fol-
lowed by the analysis using MALDI-TOF. (a) Peptide mixture; (b)
and (c) phosphopeptides isolated from 100 fmol or 50 fmol of
peptide mixture, respectively.
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phosphopeptide capture is provided in Table 1. For
simplicity, only reporter ions derived from one of the
phosphopeptides in the mix, TRDIpYETDYYRK, are
depicted in Figure 2, but the spectra are representa-
tive of the recovery efficiency observed with the other
peptides in the mix (see Supplemental Data which
can be found in the electronic version of this article).
For example, in the forward labeling experiment (F),
the intensity of reporter fragment ion 117 represent-
ing recovery from MMC-Ga3 as 10% of that of
reporter fragment ion 116 representing recovery from
MMC-Fe3. In the reverse labeling experiment (R),
the intensity of reporter fragment ion 116 represent-
ing recovery from MMC-Ga3 was 15% of that of
reporter fragment ion 117 representing recovery from
MMC-Fe3 (Figure 2a), providing confirmation that
the performance of MMC loaded with Fe3 was
superior to that with Ga3. Using the same analysis
method, the intensity of reporter fragment ions iso-
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Figure 5. Comparison of MMO to TiO2 spheres. (a) Phosphopep-
tides were isolated using either MMO or chromatographic TiO2
spheres with 0.1% TFA or 300 mg/mL DHB/80% ACN/0.1% TFA
as loading buffer, followed by the analysis of MALDI-TOF. (b)
iTRAQ-labeled phosphopeptides were isolated using either MMO
or TiO2 spheres as described above and mixed accordingly.
Phosphorylated peptides were desalted and analyzed by MALDI-
TOF-TOF.lated on MMC- Fe3 was 5-fold higher than that ofreporter fragment ions isolated on magnetic beads
functionalized with IDA-Fe3 (Figure 2b), suggesting
that the performance of MMC was better than that of
magnetic beads coupled with IDA. MMC charged
with Fe3 also performed better than Captivate beads
charged with Ga3, since their isotope ratio was
20:1 (Figure 2c). Recent reports describe zirconium
oxide particles in microtips as effective for phos-
phopeptide enrichment [13]. But based on the ob-
served isotope signal ratio of 20:1 (Figure 2d), MMC
charged with Fe3 performed significantly better
than magnetic particles functionalized with zirco-
nium oxides.
From the earliest reports of the Tempst laboratory,
Poros 20MC has became one of the most commonly
used IMAC resins [6]. Poros 20MC has an iminodiacetic
acid functional surface. When compared to Poros
20MC-Fe3, the MMC-Fe3 recovered slightly more
phosphopeptide (Figure 2e), however, the specificities
vary and the relative recovery will also depend on the
nature of the peptides (see below).
This iTRAQ labeling strategy can also be employed
to compare the relative specificity of peptide isolation
since peptides with acidic residues may also be
captured during phosphopeptide enrichment. As de-
picted in Figure 3, the MMC-Fe3 showed 50% to 70%
less contamination of unphosphorylated peptides
DRVYIHPF and DRVYIHPFHL compared with Poros
20MC-Fe3.
Chromatographic TiO2 spheres from GL Sciences
have been used successfully to isolate phosphopeptides
with high specificity by including 2,5-dihydroxybenzoic
acid (DHB) in the loading buffer [12]. For this particular
test set of peptides, the 1:1 ratio of reporter fragment ion
signals, shows that MMC-Fe3 (used without DHB)
performed as well as TiO2 spheres using DHB protocols
(Figure 2f).
Sensitivity of Phosphopeptide Enrichment
Using MMC
The sensitivity of phosphopeptide enrichment is the
key element for transduction studies as phosphory-
lation is primarily a transient, reversible event and
targeted phosphoresidues represent relatively low
abundant species. To test the sensitivity of phos-
phopeptide enrichment, peptide standard mixtures
containing either 50 or 100 fmol of phosphopeptides
were incubated with 50 g of MMC in a small PCR
tube for 10 min using repetitive aspirations. After
extensive washing, phosphopeptides were eluted
with 5 L of buffer. After desalting with a self-packed
Poros R2 tip column, phosphopeptides were eluted
directly onto a MALDI plate and mixed with the
matrix at 1:1 ratio, followed by MALDI-TOF analysis.
As depicted in Figure 4c, definitive, well resolved
signals were detected using 50 fmol of phosphopep-
tides with good selectivity and specificity. Based on
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Figure 6. Isolation of phosphopeptides from peptide extracts derived from an in-gel tryptic
digestion. Upon overnight starvation, HeLa cells labeled with SILAC light or heavy medium were
stimulated for 5 min, lysed immediately, and then mixed with equal amount of unstimulated heavy
1939J Am Soc Mass Spectrom 2007, 18, 1932–1944 QUANTITATIVE COMPARISON OF IMAC AND TiO2the signal intensity, 5 fmol of phosphopeptides
would probably be the lower limit of detection.
Quantitative Comparison of Dynabeads-TiO2 to
TiO2 Spheres
It has been reported that the addition of DHB in the
loading buffer significantly improves the specificity
of phosphopeptide enrichment when using TiO2
spheres from GL Sciences (Tokyo, Japan) [12]. How-
ever, a high concentration of DHB in the loading
buffer can reduce the flow rate of microtip column.
DHB also crystallizes readily in the loading buffer
composition, making it difficult to operate a TiO2
sphere microcolumn in fully automated fashion or
couple to reverse phase guard cartridges on-line.
Potentially, magnetic particles functionalized with
TiO2 would minimize these problems. Hence, an
isolation procedure employing MMO was used to
isolate phosphopeptides from a standard peptide
mixture with either 0.1% TFA or 300 mg/mL DHB/
80% acetonitrile/0.1% TFA as binding buffer. Based
on the resultant MALDI-TOF spectrum, the DHB
protocol provided only a minor improvement in the
specificity of phosphopeptide enrichment on MMO
for this particular set of peptides [Figure 5a left (1)].
However, for nonmagnetic, chromatographic TiO2
spheres, the DHB protocol did significantly improve
the specificity of enrichment [Figure 5a right (2)].
These results suggest that the commercial and proto-
type resins may support alternative binding interac-
tion between TiO2 and phosphopeptides and that the
solid-phase support might play an important role in
the specificity of enrichment [12].
To compare MMO directly to TiO2 spheres, the
iTRAQ labeled phosphopeptides isolated with MMO or
TiO2 spheres using the DHB protocol were mixed,
desalted, and analyzed by MALDI-TOF-TOF. As de-
picted in Figure 5b, the performance of MMO is com-
parable to TiO2 spheres based on the recovery of four
different phosphopeptides.
or light cell lysate, respectively. (a) Cell lysate m
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by examining the MS spectrum.Isolation of Phosphopeptide(s) from a Biological
Sample Using MMC or Dynabeads-TiO2
Next we evaluated the biological relevance of MMC
and MMO performance using a cell culture experi-
ments. There is increasing evidence in the literature that
SILAC is an excellent approach to study differential
protein expression and posttranslational modification,
especially phosphorylation [29, 33–37]. In this study, we
combined SILAC with MMC and MMO to quantify the
dynamic changes of tyrosine phosphorylation in re-
sponse to EGF stimulation in HeLa cells.
HeLa cells were propagated in SILAC DMEM media
containing either light or heavy Lys and Arg. After
overnight starvation, cells labeled with heavy Lys and
Arg were stimulated with EGF for 5 min while cells
labeled with light Lys and Arg remained untreated.
Cells labeled with light or heavy amino acids (50  106
cells each) were lysed immediately and mixed at 1:1
ratio based on cell number. Because phosphorylated
Tyr residues represent only 0.05% of the phosphoamino
acids within a cell [38], we followed a strategy to enrich
tyrosine phosphorylated proteins in the initial steps.
Cell lysate was incubated for 2 h with 50 g of either
phosphotyrosine antibody (PY-Plus) conjugated to
Dynabeads or 4G10 phosphotyrosine antibody conju-
gated to agarose. The magnetic or agarose beads were
washed five times with lysis buffer, followed by elution
of phosphorylated proteins with 100 mM glycine at pH
2.5 or SDS sample buffer. Samples were reduced and
alkylated, followed by separation on SDS-PAGE. Based
on Coomassie staining, more proteins were captured by
PY-Plus antibody than by 4G10 antibody (Figure 6a).
The protein bands were excised from the gel and then
subjected to in-gel tryptic digestion. The peptide ex-
tracts were dried using a speed vac.
The tryptic peptide extract from a gel band which
contains EGF receptor was analyzed by MS (Figure 6b,
Panel a). Because this mixture contains both phosphor-
ylated and nonphosphorylated peptides, interpretation
of phosphorylation would be difficult. Isolation of
phosphorylated peptides from the extracted digest mix-
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1940 LIANG ET AL. J Am Soc Mass Spectrom 2007, 18, 1932–1944Table 2. Proteins and phosphopeptides upregulated upon EGF stimulation in HeLa cells
Protein name
NCBI GI
number
Mascot
score Phosphopeptides
SILAC
ratio (H/L)
Site
observed
Citeda
already?
Recovered
byb
Annexin I 442631 213 4  0.5
ARF GTPase-activating protein
GIT1
4691726 575 3.1  0.3
Ankyrin repeat and sterile alpha
motif domain containing 1
38683797 367 4.2  0.5
Ankyrin repeat domain 13 34190139 181 4  0.5
Adaptor-related protein complex
2, beta 1 subunit isoform b
4557469 286 2.9  0.4
cbl-b 862407 953 3.5  0.4
Crk-associated substrate p130Cas 6740102 237 1.8  0.2
Cas-Br-M ecotropic retroviral
transforming sequence
52426745 848 4.2  0.5
C3orf6 protein 30089162 154 9.9  1.2
C20orf18 12697475 129 8.2  0.8
Centaurin delta 2 isoform b 16975484 706 HpYSVVLPTVSHSGFLYK 6.1  0.7 Y737 N c
Centaurin, delta 3 21264337 361 4.3  0.5
CENTD2 protein 33991628 116 8.3  0.9
Cortactin isoform a 20357552 315 LPSSPVpYEDAASFK 2.6  0.3 Y421 Y a, b, c
Dopamine receptor interacting
protein 4
33339157 172 4.1  0.5
DOCK4 29335973 219 2.7  0.3
DOC-2 1297330 299 4.1  0.5
1-8D 23396 127 4.5  0.6
EGFR protein 757924 1851 YSSDPTGALTEDSIDDTFLPVPEpYINQSVPK 20  3 Y1092 Y c
YpSSDPTGALTEDSIDDTFLPVPEpYINQpSVPK S1070 Y c
ALMDEEDMDDVVDADEpYLIPQQGFFSSPSTSR Y1018 Y c
GSHQISLDNPDpYQQDFFPK Y1172 Y a, b, c
ELVEPLpTPSGEAPNQALLR T693 Y a, b, c
MHLPSPTDSNFpYR Y998 Y a, b, c
GSTAENAEpYLR Y1197 Y a, b, c
Epidermal growth factor receptor
substrate
466260 213 7.2  0.8
Epidermal growth factor receptor
pathway substrate 15-like 1
10864047 177 3.3  0.4
Endofin 16904136 451 18  2
E3 ubiquitin-protein ligase CBL 115855 407 11.6  1.5
Epsin 2a 3894395 186 GSSQPNLSTSHSEQEpYGK 6.1  0.7 Y186 N a, b
ELMO2 protein 33111868 161 9  1.1
Focal adhesion kinase 182395 267 1.7  0.2
G protein-coupled receptor
kinase-interactor 2 isoform 1
17149830 543 3.7  0.4
G protein coupled receptor
kinase-interactor 2, isoform 4
12655059 214 2.4  0.3
GRB2-associated binding protein
1, isoform a
40674494 445 VDpYVVVDQQK 3.2  0.4 Y659 Y c
Guanine nucleotide-releasing
factor 2
57208999 107 4.9  0.6
Hepatocyte growth factor-
regulated tyrosine kinase
substrate HRS isoform 2
9022389 156 11.4  1.5
HER2 receptor 306840 712 GTPTAENPEpYLGLDVPV 16  3 Y1248 Y c
pSGGGDLTLGLEPSEEEAPR S1054 N c
Inositol polyphosphate 5-
phosphatase
2653424 1595 TLSEVDpYAPAGPAR 14  2.5 Y1135 Y a, b, c
ISGF3G protein 15082338 381 5.9  0.7
Junction plakoglobin
(Desmoplakin-3)
130257 152 4.1  0.5
Mitogen-activated protein
kinase 1
66932916 202 1.8  0.2
Myosin X 7108753 1341 3.9  0.5
NCK interacting protein with SH3
domain isoform 1
7705266 175 2.1  0.3
PI-3 kinase 3954946 706 LLGSVDpYDGINDAITR 3.5  0.4 Y228 Y a, b
Phosphatidylinositol-binding
clathrin assembly protein
25090897 209 4.9  0.6
Plcg1 3336979 932 pYQQPFEDFR 8.5  1 Y1253 Y a, b
IGTAEPDpYGALYEGR Y771 Y c
Paxillin 4506345 409 FIHQQPQSSSPVpYGSSAK 1.7  0.2 Y88 Y c
VGEEEHVpYSFPNK Y118 Y c
Polyubiquitin 2627129 402 10.5  1.5
Protein-tyrosine phosphatase 4519425 303 3.7  0.4
Rho guanine nucleotide
exchange factor (GEF) 7
55959541 918 MpSGFIYQGK 4.1  0.5 S340 Y a, b, c
pSTAALEEDAQILK S525 Y c
Rho guanine nucleotide
exchange factor 5 isoform 1
50959191 274 LESLSETPGPSpSPR 3.3  0.4 S1180 N a, b, c
DpYSTVSASPTALSTLK Y710 N c
60% similar to AB002297 2588635 157 3  0.4
w.pho
ithout
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phopeptides enriched by MMC (Figure 6b, Panel b) and
MMO (Figure 6b, Panel c) looked similar, except for
minor variances in ion abundance. Clearly, the spec-
trum is greatly simplified and, in either case, phosphor-
ylated peptides may be identified more easily.
Figure 6 illustrates a major m/z 2322.1 peptide de-
tected upon enrichment using either MMC or MMO
(Figure 6b, Panel b or c). In addition, some minor peaks
at m/z 2499.1 and 1670.6 were also observed. With
increased laser intensity, peptides at m/z 2242.0, 2419.2,
and 1590.7 were also detected. These arise, presumably,
due to the neutral loss of phosphate from their corre-
sponding parental ions at m/z 2322.1, 2499.1, and 1670.6,
respectively.
The MS/MS analysis of peptides at m/z 2499.1 and
1670.6 suggested that they were probably phosphory-
lated, as abundant neutral loss ions were notable at 80
or 98 Da below their respective precursors (data not
shown). Unfortunately, the specific phosphoresidues in
these peptides could not be assigned precisely due to
the low intensity of internal fragments in the MS/MS
spectra. On the other hand, the peptide at m/z 2322.1
was identified as the heavy, [13C6]-Lys-labeled phos-
phopeptide GSHQISLDNPDpYQQDFFPK derived
from EGFR (Figure 6b, Panel d). The fragmentation ions
that occurred on the sequence of the phosphopeptide
were indicated in Figure 6b, Panel e. A very tiny peak at
m/z 2316.1 corresponding to the light [12C6]-Lys-labeled
phosphopeptide was also detected in the MALDI-TOF
spectrum (see inset in Figure 6b, Panel c). Based on the
relative signal intensity, the tyrosine phosphorylation of
EGFR increased more than 20-fold upon EGF stimula-
Table 2. Continued
Protein name
NCBI GI
number
Mascot
score Ph
Signal transducing adaptor
molecule 1
4507249 654
Signal transducing adaptor
molecule 2
20381123 710
Signal transducer and activator
of transcription Stat5B
1330324 132 AVDGpYVKPQIK
SHC1 protein 17380299 216 ELFDDPSpYVNVQ
Spermatogenesis associated PD1 4730927 149
Tight junction protein ZO-1 292938 402
Tyrosine kinase, non-receptor, 2
isoform 1
56549666 599 pYATPQVIQAPGP
Target of myb1-like protein 2 18698597 114
Vav 2 oncogene 40549448 275
VAV-3 protein 3928847 759
Valosin containing protein 29144989 131
Unnamed protein product 34530097 434
Unknown 14249875 173
KIAA0849 protein 14133221 587
Phosphoprotein controls
Ephrin receptor EphA2 22713539 574 QSPEDVpYFSK
VLEDDPEATpYTT
TRAP150 4530441 404 ASAVSELpSPR
IDIpSPSTFR
BCL2-associated transcription
factor 1
7661958 125 IDIpSPSTLR
aAccording to peer-reviewed work as referenced on PhosphoSite® URL: http://ww
bThe phosphopeptides were recovered using MMC-Fe (a) or MMO-TiO2 (b) and wtion for 5 min.The same heavy [13C6]-Lys-labeled phosphopeptide
GSHQISLDNPDpYQQDFFPKwas identified and quan-
tified in separate nanoelectrospray LC-MS experiments
(Figure 6c, Panels a and b). In Panel a, cells labeled with
light Lys and Arg were stimulated with EGF and then
mixed with equal amount of unstimulated cells previ-
ously labeled with heavy Lys and Arg (forward stimu-
lation, F). Whereas in Panel b, cell lysate mixture was
prepared from unstimulated light-labeled cells and
EGF-stimulated heavy-labeled cells (reverse stimula-
tion, R). Detection of the immonium ion at m/z 216.02 is
specific for tyrosine-phosphorylated peptide. The iden-
tities of the light [12C6]-Lys-labeled phosphopeptide
(Figure 6c, Panel c) and the heavy [13C6]-Lys-labeled
phosphopeptide (Figure 6c, Panel d) were confirmed by
MS/MS scans. The b ion series derived from light or
heavy labeled peptides are identical, but the y ion series
derived from heavy labeled peptide are 6 Da larger than
that of light labeled peptide because a lysine residue is
present at C-terminus of the phosphopeptide (data not
shown). In the forward stimulation experiment, a very
tiny peak with 3 Da mass units higher than the precur-
sor ion in the MS scan represented the heavy [13C6]-Lys-
labeled phosphopeptide (Figure 6c, Panel a), whereas a
very small peak with 3 Da mass units lower than the
precursor ion in the MS scan represented the light
[12C6]-Lys-labeled phosphopeptide in the reverse stim-
ulation experiment (Figure 6c, Panel b). An additional
peak at m/z 1164.5 (Figure 6c, Panel b) was due to the
metabolic conversion of arginine to proline [37]. The
signal intensity ratio of EGF-stimulated phosphopep-
tide to unstimulated phosphopeptide was greater than
20:1, which is consistent with the result obtained by
peptides
SILAC
ratio (H/L)
Site
observed
Citeda
already?
Recovered
byb
6  0.8
7.1  0.9
5.4  0.6 Y699 Y c
3.5  0.4 Y427 Y a, b, c
10.5  1.2
2.8  0.3
2.2  0.3 Y826 Y c
5.9  0.8
5.0  0.6
3.1  0.3
2.7  0.3
9.3  1.2
17  3
6.2  0.8
1 Y575 N c
Y772 Y c
1 S243 Y c
S6812 Y c
1 S658 Y c
sphosite.org.
treatment (c).ospho
NLDK
R
SGGKMALDI-TOF-TOF analysis. These results indicated that
1942 LIANG ET AL. J Am Soc Mass Spectrom 2007, 18, 1932–1944the MMC or MMO effectively isolated phosphopep-
tides from in-gel tryptic digest with good selectivity
and specificity.
In this study, 62 gene products were up-regulated in
response to EGF stimulation (Table 2). Results reported
are the culmination of three biological replicates. The
majority of the proteins have been previously charac-
terized by Mann’s or White’s research groups in the
proteomic analysis of EGF signaling network [20, 39].
However, additional proteins, such as ankyrin repeat,
annexin I, adaptor-related protein complex 2, C3orf6
protein, centaurin, DOCK4, spermatogenesis associated
PD1, and endofin, have not been reported. Ankyrin
plays a structural role by binding to both integral
membrane proteins and spectrin/fodrin proteins of the
cytoskeleton. It has been shown that the cytoskeletal
association of ankyrin is down-regulated by phosphor-
ylation via its cooperative interaction with spectrin and
protein 3 [40–42]. Growth hormone induces tyrosine
phosphorylation of annexin I in rat osteosarcoma cells
and EGF stimulates annexin 1-dependent inward vesic-
ulation in a multivesicular endosome subpopulation.
During the processing of epidermal growth factor re-
ceptors, annexin I is phosphorylated in the multivesicu-
lar body [43–45].
C3orf6 protein (Ymer) is phosphorylated at tyrosine
145 and 146 upon EGF stimulation. Phosphorylated
Ymer is also associated with EGF receptor and func-
tions in its endocytosis and degradation [46]. Cen-
taurins are a family of proteins that contain GTPase
activating protein domains. It has been reported that
centaurin-alpha1 contributes to ERK activation in
growth factor signaling, linking the PI3K pathway to
the ERK mitogen-activated protein kinase pathway
through its ability to interact with PIP3 [47].
Spermatogenesis associated PD1 (SPATA2) is highly
hydrophilic, serine-rich, and contains 17 cysteine resi-
dues that are located predominantly in the C-terminal
domain. It has been proposed that SPATA2 contains
several potential phosphorylation sites [48].
With the aid of MMC or MMO resins, 22 distinct
tyrosine phosphorylation sites and nine serine or thre-
onine phosphorylation sites were characterized. With
the exception of six residues, all of the phosphorylation
sites have been previously reported by White’s research
group [39]. However, several novel phosphorylation
sites on HER2 receptor, centaurin, epsin 2a, and EphA2
were identified (Table 2). Investigators studying
HEK293 cells noted that, in response to fibronectin
attachment, centaurin-3 (ARAP3) undergoes rapid and
robust phosphorylation and that down regulation of
centaurin-3 phosphorylation controls RhoGTPase and
cell spreading [49]. The rat epsin and Eps15 are mitotic
phosphoproteins and their mitotic phosphorylation in-
hibits binding to the clathrin adaptor AP-2, regulating
clathrin-mediated endocytosis [50].
Some signaling molecules, such as MAP kinase, are
phosphorylated on both tyrosine and threonine/serine
residues. By using anti-phosphotyrosine antibodies toimmunoprecipitate protein and protein complexes
rather than tryptic peptides, additional Ser or Thr
phosphorylation sites may be identified on tyrosine
phosphorylated proteins and their binding partners.
For example, in addition to tyrosine phosphorylation,
threonine and serine phosphorylation of EGFR were
also observed. Threonine phosphorylation of EGFR has
been shown to play an important role in regulating the
tyrosine kinase activity of EGFR [51]. These results
indicate that a combined approach of SILAC with
IMAC or TiO2 enables quantification of phosphoryla-
tion networks, even dynamic change at specific resi-
dues. Ubiquitination of the phosphorylated EGF recep-
tor (EGFR) occurs upon binding Cbl, and this plays an
important role in regulating both EGFR localization and
degradation. It is therefore not unusual to find that
tryptic peptides of ubiquitin recovered in the EGFR gel
band respond to EGF stimulation with a 10-fold abun-
dance change [52].
Conclusion
Characterization of metal chelate resins and metal oxide
surfaces is most informative if performed in a quanti-
tative fashion. In this study, we demonstrate that
iTRAQ is an excellent approach to evaluate the perfor-
mance of IMAC and metal oxide resins quantitatively.
In general, the chelating resins in this study performed
better when loaded with Fe3 than those loaded with
Ga3. The MMC-Fe3 described herein tends to have
less nonspecific binding than the Poros 20MC-Fe3
resins. Moreover, the specificity and sensitivity of MMC
are comparable to MMO or TiO2 spheres when the
present protocol is employed. The enrichment of phos-
phopeptides from MMC or MMO virtually eliminated
the problem of suppression by unphosphorylated pep-
tides, although absolute purity of the eluates was not
achieved.
To further evaluate the performance of MMC and
MMO, we devised a combined approach of SILAC,
immunoaffinity isolation of phosphoproteins and MMC
or MMO capture of phosphopeptides to quantify the
dynamic changes of phosphorylation in response to
EGF stimulation. Previously, Mann et al. used SILAC
approach to monitor tyrosine phosphorylation at the
protein level without site specification [20]. White et al.
combined iTRAQ and IMAC to study the systems
biological response of EGF signaling cascades, generat-
ing time course studies of phosphorylation profiles for
78 tyrosine phosphorylation sites on 58 proteins [39].
In this study, we identified more than 62 proteins
and 36 phosphopeptides up-regulated upon EGF stim-
ulation, but we did not detect all expected phosphory-
lation sites. This could be partially explained by the fact
that certain peptides were not amenable to MALDI-
TOF-TOF or LC/MS analysis because of low abun-
dance, unsuitable size, or poor ionization efficiency.
Moreover, the neutral loss of phosphoric acid derived
was observed as the most intense fragment ions in the
1943J Am Soc Mass Spectrom 2007, 18, 1932–1944 QUANTITATIVE COMPARISON OF IMAC AND TiO2MS/MS spectra of many phosphopeptides, leaving the
majority of the spectrum difficult to interpret. White et
al. utilized an optimized IMAC protocol to enrich
phosphorylated peptides from a tryptic digest of pro-
teins isolated from liver lysate, reporting the identifica-
tion of more than 300 phosphorylation sites when
including Mascot Score 15 or above [53]. Although we
have identified numerous putative phosphopeptides
with Mascot Score 15 or above, we have not included
those alignments in our report because the confidence
of protein identification is insufficient. One-peptide hits
within this combined dataset rank below 40% confi-
dence. Although this in not inconsistent with other
larger studies, Oda and colleagues demonstrate that
MS/MS/MS analysis on peptides with neutral loss
could dramatically improve the identification of phos-
phopeptides [54].
Taken together, immunoprecipitation by anti-phos-
photyrosine antibody followed by IMAC or metal ox-
ides has proven to be a successful approach to identify
tyrosine phosphorylated proteins/peptides. Combing
SILAC and IMAC, one could study the dynamic regu-
lation of phosphorylation at specific sites, upon stimu-
lation with growth factors or drug treatment.
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